Vyome Holdings (HIND) Other Working Capital Changes (2015 - 2026)
Vyome Holdings (HIND) posted quarterly Other Working Capital Changes of -$61000.0 for Q4 2020, down 143.26% year-over-year from $141000.0 in Q1 2020, and little changed quarter-over-quarter from -$61000.0 in Q3 2020.
Vyome Holdings (HIND) Other Working Capital Changes (2015 - 2026) Analysis & Trends
Vyome Holdings' Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$61000.0 for Q4 2020.
- In Q4 2020, Other Working Capital Changes fell 143.26% year-over-year to -$61000.0; the TTM figure through Mar 2021 stood at -$462000.0 (down 602.17% YoY), while the FY2020 annual figure was -$424000.0, down 688.89% from the prior year.
- Other Working Capital Changes for Q4 2020 stood at -$61000.0, roughly flat from -$61000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $384254.0 in Q2 2025, with the low at -$490000.0 in Q2 2022.
- The 5-year median for Other Working Capital Changes is -$78000.0 (2024), against an average of -$68065.4.
- The sharpest annual moves came in 2019 and 2020: Other Working Capital Changes plunged 3600.0% in 2019, then soared 111.11% in 2020.
- Vyome Holdings' Other Working Capital Changes stood at -$13000.0 in 2017, then soared by 92.31% to -$1000.0 in 2018, then surged by 14200.0% to $141000.0 in 2019, then slumped by 143.26% to -$61000.0 in 2020.
- Business Quant data shows HIND's Other Working Capital Changes at -$61000.0 in Q4 2020, -$61000.0 in Q3 2020, and -$340000.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.54 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.27 Bn | 60.09 Bn | 1.37 Bn |
| 4 | Moderna | 59.41 Bn | 54.27 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.44 Bn | - |
| 10 | Vyome Holdings | 16.00 Mn | 8.11 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -102,812.00 |
| Jun 30, 2026 | -102,812.00 |
| Jun 30, 2026 | -102,812.00 |
| Mar 31, 2026 | -33,387.00 |
| Mar 31, 2026 | -33,387.00 |
| Mar 31, 2026 | -33,387.00 |
| Dec 31, 2025 | -296,793.00 |
| Dec 31, 2025 | -296,793.00 |
| Dec 31, 2025 | -296,793.00 |
| Sep 30, 2025 | -138,189.00 |
| Sep 30, 2025 | -138,189.00 |
| Sep 30, 2025 | -138,189.00 |
| Jun 30, 2025 | 384,254.00 |
| Jun 30, 2025 | 384,254.00 |
| Jun 30, 2025 | 384,254.00 |
| Mar 31, 2025 | -25,254.00 |
| Mar 31, 2025 | -25,254.00 |
| Mar 31, 2025 | -25,254.00 |
| Dec 31, 2024 | -78,629.00 |
| Dec 31, 2024 | -78,629.00 |